M&N's CBD to Exhibit at "Cavalier Festival 2026 SPRING"
M&N's CBD, a biotech startup specializing in new material research and commercialization, will exhibit at the "Cavalier Festival 2026 SPRING." The company has developed over 200 CBD products, successfully researched nano-CBD formulations, and raised approximately 150 million JPY in May 2022.
📋 Article Processing Timeline
- 📰 Published: April 22, 2026 at 09:00
- 🔍 Collected: April 22, 2026 at 09:31 (31 min after Published)
- 🤖 AI Analyzed: April 22, 2026 at 10:19 (48 min after Collected)
A biotech startup engaged in the research and commercialization of new materials. In addition to planning and developing over 200 CBD products, it has succeeded in the industry's first research into nano-CBD formulations that dramatically enhance CBD absorption efficiency. In May 2022, it raised approximately 150 million JPY in Series A funding. CBD products are already distributed to over 500 stores nationwide, including medical institutions.